-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, AuFFlNuvRg8CNFAsIZSh0HHHYtDgbAFOdQ14URNGbokBQJURHm+IHxZk7Fwf1ccO 27V5ImkrbMkvplRLZXPwfg== 0001230295-07-000600.txt : 20071005 0001230295-07-000600.hdr.sgml : 20071005 20071005142654 ACCESSION NUMBER: 0001230295-07-000600 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20071003 FILED AS OF DATE: 20071005 DATE AS OF CHANGE: 20071005 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hamelin Paul CENTRAL INDEX KEY: 0001364190 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-15313 FILM NUMBER: 071158888 BUSINESS ADDRESS: BUSINESS PHONE: 732-418-9300 MAIL ADDRESS: STREET 1: C/O SAVIENT PHARMACEUTICALS, INC. STREET 2: ONE TOWER CENTER BOULEVARD, 14TH FLOOR CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SAVIENT PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000722104 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 133033811 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE TOWER CENTER CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 BUSINESS PHONE: 7324189300 MAIL ADDRESS: STREET 1: ONE TOWER CENTER CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 FORMER COMPANY: FORMER CONFORMED NAME: BIO TECHNOLOGY GENERAL CORP DATE OF NAME CHANGE: 19920703 4 1 ham200.xml X0202 4 2007-10-03 0 0000722104 SAVIENT PHARMACEUTICALS INC SVNT 0001364190 Hamelin Paul C/O SAVIENT PHARMACEUTICALS, INC ONE TOWER CENTER BLVD., 14TH FLOOR EAST BRUNSWICK NJ 08816 0 1 0 0 SVP, Commercial Operations Common Stock, $.01 par value per share 2007-10-03 4 M 0 2500 5.1100 A 46140 D Common Stock, $.01 par value per share 2007-10-03 4 S 0 2500 15.5200 D 43640 D Option to Purchase Common Stock, $.01 par value 5.1100 2007-10-03 4 M 0 2500 0 D 2007-05-23 2016-05-23 Common Stock, $.01 par value per share 2500 57500 D This sale was made pursuant to a trading plan adopted on June 14, 2007 by the reporting person in accordance with Rule 105b-1 under the Securities Exchange Act of 1934. By: /s/ Irina Azer as Attorney-In-Fact for 2007-10-05 -----END PRIVACY-ENHANCED MESSAGE-----